Hee-Je Kim (Kim Hee-Je, Hee Je Kim)

ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 53

Top Venues

Cancers

Bone marrow transplantation

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Blood advances

Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea Apr 01 1998

South Korea

Professor :: Hematology

Publications

Gail J Roboz, Guillermo F Sanz, Elizabeth A Griffiths, Karen W L Yee, Hagop Kantarjian, Christian Récher, Michael T Byrne, Elżbieta Patkowska, Hee-Je Kim, Xavier Thomas, Ine Moors, Wendy Stock, Árpád Illés, Pierre Fenaux, Yasushi Miyazaki, Takahiro Yamauchi, Casey L O'Connell, Yong Hao, Harold N Keer, Mohammad Azab, Hartmut Döhner
Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial. Blood advances 8 (8) (2024)
Mark J Levis, Mehdi Hamadani, Brent R Logan, Richard J Jones, Anurag K Singh, Mark R Litzow, John R Wingard, Esperanza B Papadopoulos, Alexander E Perl, Robert J Soiffer, Celalettin Ustun, Masumi Ueda Oshima, Geoffrey L Uy, Edmund K Waller, Sumithra Vasu, Melham M Solh, Asmita Mishra, Lori S Muffly, Hee-Je Kim, Jan-Henrik Mikesch, Yuho Najima, Masahiro Onozawa, Kirsty Thomson, Arnon Nagler, Andrew H Wei, Guido Marcucci, Nancy L Geller, Nahla Hasabou, David Delgado, Matt Rosales, Jason E Hill, Stanley C Gill, Rishita Nuthethi, Denise King, Heather Wittsack, Adam Mendizabal, Steven M Devine, Mary M Horowitz, Yi-Bin Chen, null null
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3 . Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Mark J Levis, Mehdi Hamadani, Brent R Logan, Richard J Jones, Anurag K Singh, Mark R Litzow, John R Wingard, Esperanza B Papadopoulos, Alexander E Perl, Robert J Soiffer, Celalettin Ustun, Masumi Ueda Oshima, Geoffrey L Uy, Edmund K Waller, Sumithra Vasu, Melham M Solh, Asmita Mishra, Lori S Muffly, Hee-Je Kim, Jan-Henrik Mikesch, Yuho Najima, Masahiro Onozawa, Kirsty Thomson, Arnon Nagler, Andrew H Wei, Guido Marcucci, Nancy L Geller, Nahla Hasabou, David Delgado, Matt Rosales, Jason E Hill, Stanley C Gill, Rishita Nuthethi, Denise King, Heather Wittsack, Adam Mendizabal, Steven M Devine, Mary M Horowitz, Yi-Bin Chen, null null
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3 . Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Gail J Roboz, Guillermo F Sanz, Elizabeth A Griffiths, Karen W L Yee, Hagop Kantarjian, Christian Récher, Michael T Byrne, Elżbieta Patkowska, Hee-Je Kim, Xavier Thomas, Ine Moors, Wendy Stock, Árpád Illés, Pierre Fenaux, Yasushi Miyazaki, Takahiro Yamauchi, Casey L O'Connell, Yong Hao, Harold N Keer, Mohammad Azab, Hartmut Döhner
Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial. Blood advances 8 (8) (2024)
Silvia Park, Su-Yeon Bang, Daehun Kwag, Jong Hyuk Lee, Tong Yoon Kim, Joonyeop Lee, Gi June Min, Sung Soo Park, Seung-Ah Yahng, Young-Woo Jeon, Seung Hwan Shin, Sung Soo Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Sung-Eun Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1. Bone marrow transplantation 59 (6) (2024)
Silvia Park, Su-Yeon Bang, Daehun Kwag, Jong Hyuk Lee, Tong Yoon Kim, Joonyeop Lee, Gi June Min, Sung Soo Park, Seung-Ah Yahng, Young-Woo Jeon, Seung Hwan Shin, Sung Soo Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Sung-Eun Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1. Bone marrow transplantation 59 (6) (2024)
Gail J Roboz, Guillermo F Sanz, Elizabeth A Griffiths, Karen W L Yee, Hagop Kantarjian, Christian Récher, Michael T Byrne, Elżbieta Patkowska, Hee-Je Kim, Xavier Thomas, Ine Moors, Wendy Stock, Árpád Illés, Pierre Fenaux, Yasushi Miyazaki, Takahiro Yamauchi, Casey L O'Connell, Yong Hao, Harold N Keer, Mohammad Azab, Hartmut Döhner
Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial. Blood advances 8 (8) (2024)
Mark J Levis, Mehdi Hamadani, Brent R Logan, Richard J Jones, Anurag K Singh, Mark R Litzow, John R Wingard, Esperanza B Papadopoulos, Alexander E Perl, Robert J Soiffer, Celalettin Ustun, Masumi Ueda Oshima, Geoffrey L Uy, Edmund K Waller, Sumithra Vasu, Melham M Solh, Asmita Mishra, Lori S Muffly, Hee-Je Kim, Jan-Henrik Mikesch, Yuho Najima, Masahiro Onozawa, Kirsty Thomson, Arnon Nagler, Andrew H Wei, Guido Marcucci, Nancy L Geller, Nahla Hasabou, David Delgado, Matt Rosales, Jason E Hill, Stanley C Gill, Rishita Nuthethi, Denise King, Heather Wittsack, Adam Mendizabal, Steven M Devine, Mary M Horowitz, Yi-Bin Chen, null null
Gilteritinib as Post-Transplant Maintenance for Acute Myeloid Leukemia With Internal Tandem Duplication Mutation of FLT3 . Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Silvia Park, Su-Yeon Bang, Daehun Kwag, Jong Hyuk Lee, Tong Yoon Kim, Joonyeop Lee, Gi June Min, Sung Soo Park, Seung-Ah Yahng, Young-Woo Jeon, Seung Hwan Shin, Sung Soo Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Sung-Eun Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1. Bone marrow transplantation (2024)
Jaehyun Ahn, Sung Soo Park, Daehun Kwag, Gi June Min, Sung Soo Park, Silvia Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, Chang-Ki Min, Seok-Goo Cho, Sung-Eun Lee
Comparative analysis of reduced toxicity conditioning regimens between fludarabine plus melphalan and fludarabine plus busulfex in adult patients with acute lymphoblastic leukemia. Bone marrow transplantation (2024)
Soon Kyu Lee, Sung Soo Park, Silvia Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Seok Lee, Younghoon Kim, Ji-Won Han, Hyun Yang, Si Hyun Bae, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Dong Yeup Lee, Sung Hak Lee, Sung Soo Park, Pil-Soo Sung
The Impact of Histologic Portal T-Cell Density on the Clinical Outcomes in Hepatic Graft-versus-Host Disease and Autoimmune Liver Diseases. Diagnostics (Basel, Switzerland) 14 (16) (2024)
Gail J Roboz, Guillermo F Sanz, Elizabeth A Griffiths, Karen W L Yee, Hagop Kantarjian, Christian Récher, Michael T Byrne, Elżbieta Patkowska, Hee-Je Kim, Xavier Thomas, Ine Moors, Wendy Stock, Árpád Illés, Pierre Fenaux, Yasushi Miyazaki, Takahiro Yamauchi, Casey L O'Connell, Yong Hao, Harold N Keer, Mohammad Azab, Hartmut Döhner
Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial. Blood advances 8 (8) (2024)
Mark J Levis, Mehdi Hamadani, Brent R Logan, Richard J Jones, Anurag K Singh, Mark R Litzow, John R Wingard, Esperanza B Papadopoulos, Alexander E Perl, Robert J Soiffer, Celalettin Ustun, Masumi Ueda Oshima, Geoffrey L Uy, Edmund K Waller, Sumithra Vasu, Melham M Solh, Asmita Mishra, Lori S Muffly, Hee-Je Kim, Jan-Henrik Mikesch, Yuho Najima, Masahiro Onozawa, Kirsty Thomson, Arnon Nagler, Andrew H Wei, Guido Marcucci, Nancy L Geller, Nahla Hasabou, David Delgado, Matt Rosales, Jason E Hill, Stanley C Gill, Rishita Nuthethi, Denise King, Heather Wittsack, Adam Mendizabal, Steven M Devine, Mary M Horowitz, Yi-Bin Chen, null null
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3 . Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Mark J Levis, Mehdi Hamadani, Brent R Logan, Richard J Jones, Anurag K Singh, Mark R Litzow, John R Wingard, Esperanza B Papadopoulos, Alexander E Perl, Robert J Soiffer, Celalettin Ustun, Masumi Ueda Oshima, Geoffrey L Uy, Edmund K Waller, Sumithra Vasu, Melham M Solh, Asmita Mishra, Lori S Muffly, Hee-Je Kim, Jan-Henrik Mikesch, Yuho Najima, Masahiro Onozawa, Kirsty Thomson, Arnon Nagler, Andrew H Wei, Guido Marcucci, Nancy L Geller, Nahla Hasabou, David Delgado, Matt Rosales, Jason E Hill, Stanley C Gill, Rishita Nuthethi, Denise King, Heather Wittsack, Adam Mendizabal, Steven M Devine, Mary M Horowitz, Yi-Bin Chen, null null
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3 . Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Silvia Park, Su-Yeon Bang, Daehun Kwag, Jong Hyuk Lee, Tong Yoon Kim, Joonyeop Lee, Gi June Min, Sung Soo Park, Seung-Ah Yahng, Young-Woo Jeon, Seung Hwan Shin, Sung Soo Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Sung-Eun Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1. Bone marrow transplantation 59 (6) (2024)
Silvia Park, Su-Yeon Bang, Daehun Kwag, Jong Hyuk Lee, Tong Yoon Kim, Joonyeop Lee, Gi June Min, Sung Soo Park, Seung-Ah Yahng, Young-Woo Jeon, Seung Hwan Shin, Sung Soo Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Sung-Eun Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1. Bone marrow transplantation 59 (6) (2024)
Gail J Roboz, Guillermo F Sanz, Elizabeth A Griffiths, Karen W L Yee, Hagop M Kantarjian, Christian Récher, Michael T Byrne, Elzbieta Patkowska, Hee-Je Kim, Xavier Thomas, Ine Moors, Wendy Stock, Arpad Illes, Pierre Fenaux, Yasushi Miyazaki, Takahiro Yamauchi, Casey O'Connell, Yong Hao, Harold Neal Keer, Mohammad Azab, Hartmut Döhner
Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: randomized phase 3 ASTRAL-2 trial. Blood advances (2024)
Mark J Levis, Mehdi Hamadani, Brent R Logan, Richard J Jones, Anurag K Singh, Mark R Litzow, John R Wingard, Esperanza B Papadopoulos, Alexander E Perl, Robert J Soiffer, Celalettin Ustun, Masumi Ueda Oshima, Geoffrey L Uy, Edmund K Waller, Sumithra Vasu, Melham M Solh, Asmita Mishra, Lori S Muffly, Hee-Je Kim, Jan-Henrik Mikesch, Yuho Najima, Masahiro Onozawa, Kirsty Thomson, Arnon Nagler, Andrew H Wei, Guido Marcucci, Nancy L Geller, Nahla Hasabou, David Delgado, Matt Rosales, Jason E Hill, Stanley C Gill, Rishita Nuthethi, Denise King, Heather Wittsack, Adam Mendizabal, Steven M Devine, Mary M Horowitz, Yi-Bin Chen, null null
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3 . Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Dukhee Nho, Raeseok Lee, Sung-Yeon Cho, Dong-Gun Lee, Eun-Jin Kim, Silvia Park, Sung-Eun Lee, Byung-Sik Cho, Yoo-Jin Kim, Seok Lee, Hee-Je Kim
Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation under 100-Day Letermovir Prophylaxis: A Real-World 1-Year Follow-Up Study. Viruses 15 (9) (2023)
Howon Lee, Jay Ho Han, Jae Kwon Kim, Jaeeun Yoo, Sung Soo Park, Byung-Sik Cho, Hee-Je Kim, Jihyang Lim, Dong Wook Jekarl, Yonggoo Kim
Machine Learning Predicts 30-Day Outcome among Acute Myeloid Leukemia Patients: A Single-Center, Retrospective, Cohort Study. Journal of clinical medicine 12 (18) (2023)
Su-Yeon Bang, Silvia Park, Daehun Kwag, Jong Hyuk Lee, Gi-June Min, Sung-Soo Park, Sung Soo Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
A Successful Bridge Therapy Combining Hypomethylating Agents with Venetoclax for Adult Patients with Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia. Cancers 15 (6) (2023)
Han Sun Kim, Bo-Reum Kim, Thien T P Dao, Jin-Mo Kim, Yoon-Joo Kim, Hyunsong Son, Sihyang Jo, Doyeon Kim, Jiwoo Kim, Young Ju Suh, Hee-Je Kim, Byung-Sik Cho, Sunghyouk Park
TAK-981, a SUMOylation inhibitor, suppresses AML growth immune-independently. Blood advances (2023)
Eun-Jeong Choi, In-Cheol Baek, Silvia Park, Hee-Je Kim, Tai-Gyu Kim
Development of cost-effective and fast KIR genotyping by multiplex PCR-SSP. HLA (2023)
Jong Hyuk Lee, Byung-Sik Cho, Daehun Kwag, Gi-June Min, Sung Soo Park, Silvia Park, Sung Soo Park, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Jong-Wook Lee, Hee-Je Kim
Haploidentical versus Double-Cord Blood Stem Cells as a Second Transplantation for Relapsed Acute Myeloid Leukemia. Cancers 15 (2) (2023)
Jong Hyuk Lee, Byung-Sik Cho, Daehun Kwag, Gi-June Min, Sung Soo Park, Silvia Park, Sung Soo Park, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Jong-Wook Lee, Hee-Je Kim
Haploidentical versus Double-Cord Blood Stem Cells as a Second Transplantation for Relapsed Acute Myeloid Leukemia. Cancers 15 (2) (2023)
Jin Jung, Daehun Kwag, Yonggoo Kim, Jong-Mi Lee, Ari Ahn, Hoon Seok Kim, Byunggyu Bae, Silvia Park, Hee-Je Kim, Byung-Sik Cho, Myung-Shin Kim
Perspectives on acute myeloid leukemia diagnosis: a comparative analysis of the latest World Health Organization and the International Consensus Classifications. Leukemia (2023)
Su-Yeon Bang, Silvia Park, Daehun Kwag, Jong Hyuk Lee, Gi-June Min, Sung-Soo Park, Sung Soo Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
A Successful Bridge Therapy Combining Hypomethylating Agents with Venetoclax for Adult Patients with Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia. Cancers 15 (6) (2023)
Tong-Yoon Kim, Daehun Kwag, Jong-Hyuk Lee, Joonyeop Lee, Gi-June Min, Sung Soo Park, Silvia Park, Young-Woo Jeon, Jae-Ho Yoon, Seung-Hawn Shin, Seung-Ah Yahng, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Sung-Eun Lee, Hee-Je Kim, Chang-Ki Min, Seok-Goo Cho, Jong-Wook Lee, Jong-Mi Lee, Myung-Shin Kim, Sung-Eun Lee
Clinical Features, Gene Alterations, and Outcomes in Prefibrotic and Overt Primary and Secondary Myelofibrotic Patients. Cancers 14 (18) (2022)
Alexander E Perl, Richard A Larson, Nikolai A Podoltsev, Stephen Strickland, Eunice S Wang, Ehab Atallah, Gary J Schiller, Giovanni Martinelli, Andreas Neubauer, Jorge Sierra, Pau Montesinos, Christian Recher, Sung Soo Yoon, Naoko Hosono, Masahiro Onozawa, Shigeru Chiba, Hee-Je Kim, Nahla Hasabou, Qiaoyang Lu, Ramon Tiu, Mark J Levis
Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial. Blood 139 (23) (2022)
Daehun Kwag, Byung-Sik Cho, Su-Yeon Bang, Jong Hyuk Lee, Gi-June Min, Sung Soo Park, Silvia Park, Sung Soo Park, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Sung-Eun Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis. Blood cancer journal 12 (12) (2022)
Jong-Mi Lee, Silvia Park, Insik Hwang, Dain Kang, Byung Sik Cho, Hee-Je Kim, Ari Ahn, Myung-Shin Kim, Yonggoo Kim
FLT3 -ITD Measurable Residual Disease Monitoring in Acute Myeloid Leukemia Using Next-Generation Sequencing. Cancers 14 (24) (2022)
Tong-Yoon Kim, Silvia Park, Daehun Kwag, Jong-Hyuk Lee, Joonyeop Lee, Gi-June Min, Sung Soo Park, Young-Woo Jeon, Seung-Hawn Shin, Seung-Ah Yahng, Jae-Ho Yoon, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Sung-Eun Lee, Chang-Ki Min, Seok-Goo Cho, Jong-Wook Lee, Hee-Je Kim
Depth of Response to Intensive Chemotherapy Has Significant Prognostic Value among Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation with Intermediate or Adverse Risk at Diagnosis Compared to At-Risk Group According to European Leukemia Net 2017 Risk Stratification. Cancers 14 (13) (2022)
Gi-June Min, Byung-Sik Cho, Sung-Soo Park, Silvia Park, Young-Woo Jeon, Seung-Hwan Shin, Seung-Ah Yahng, Sung Soo Park, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Chang-Ki Min, Seok-Goo Cho, Dong-Wook Kim, Jong Wook Lee, Hee-Je Kim
Geriatric assessment predicts nonfatal toxicities and survival for intensively treated older adults with AML. Blood 139 (11) (2022)
Seungjoon Lee, Eunsaem Lee, Sung Soo Park, Min Sue Park, Jaewoo Jung, Gi June Min, Silvia Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Sung-Eun Lee, Hee-Je Kim, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hyung Ju Hwang, Sung Soo Park
Prediction and recommendation by machine learning through repetitive internal validation for hepatic veno-occlusive disease/sinusoidal obstruction syndrome and early death after allogeneic hematopoietic cell transplantation. Bone marrow transplantation 57 (4) (2022)
Dain Kang, Jin Jung, Silvia Park, Byung-Sik Cho, Hee-Je Kim, Yeojae Kim, Jong-Mi Lee, Hoon Seok Kim, Ari Ahn, Myung-Shin Kim, Yonggoo Kim
Genetic Characteristics According to Subgroup of Acute Myeloid Leukemia with Myelodysplasia-Related Changes. Journal of clinical medicine 11 (9) (2022)
Daehun Kwag, Byung-Sik Cho, Su-Yeon Bang, Jong Hyuk Lee, Gi-June Min, Sung Soo Park, Silvia Park, Sung Soo Park, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Sung-Eun Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis. Blood cancer journal 12 (12) (2022)
Daehun Kwag, Byung-Sik Cho, Su-Yeon Bang, Jong Hyuk Lee, Gi-June Min, Sung Soo Park, Silvia Park, Sung Soo Park, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Sung-Eun Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis. Blood cancer journal 12 (12) (2022)
Jong-Mi Lee, Silvia Park, Insik Hwang, Dain Kang, Byung Sik Cho, Hee-Je Kim, Ari Ahn, Myung-Shin Kim, Yonggoo Kim
FLT3 -ITD Measurable Residual Disease Monitoring in Acute Myeloid Leukemia Using Next-Generation Sequencing. Cancers 14 (24) (2022)
Daehun Kwag, Byung-Sik Cho, Su-Yeon Bang, Jong Hyuk Lee, Gi-June Min, Sung Soo Park, Silvia Park, Sung Soo Park, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Sung-Eun Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis. Blood cancer journal 12 (12) (2022)
Ga-Young Song, TaeHyung Kim, Seo-Yeon Ahn, Sung-Hoon Jung, Mihee Kim, Deok Hwan Yang, Je-Jung Lee, Seung Hyun Choi, Mi Yeon Kim, Chul Won Jung, Jun-Ho Jang, Hee-Je Kim, Joon-Ho Moon, Sang Kyun Sohn, Jong-Ho Won, Seong-Kyu Park, Sung-Hyun Kim, Zhaolei Zhang, Jae-Sook Ahn, Hyeoung-Joon Kim, Dennis Dong Hwan Kim
Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia. Bone marrow transplantation 57 (12) (2022)
Stéphane de Botton, Pau Montesinos, Andre Schuh, Cristina Papayannidis, Paresh Vyas, Andrew H Wei, Hans Beier Ommen, Sergey Semochkin, Hee-Je Kim, Richard A Larson, Jamie Koprivnikar, Olga Frankfurt, Felicitas R Thol, Jörg Chromik, Jenny L Byrne, Arnaud Pigneux, Xavier Thomas, Olga Salamero, María-Belén Vidriales, Vadim A Doronin, Hartmut Döhner, Amir T Fathi, Eric Laille, Xin Yu, Maroof Hasan, Patricia Martín-Regueira, Courtney D D DiNardo
Enasidenib vs conventional care in mutant-IDH2 relapsed/refractory acute myeloidleukemia: a randomized, phase 3 trial. Blood (2022)
Joonhong Park, Hoon Seok Kim, Jong-Mi Lee, Jin Jung, Dain Kang, Hayoung Choi, Gun Dong Lee, Jungok Son, Silvia Park, Byung-Sik Cho, Hee-Je Kim, Seongkoo Kim, Jae Wook Lee, Nack-Gyun Chung, Bin Cho, Hua Zhang, Nickolay A Khazanov, Jongpill Choi, Jae-Won Jung, Yonggoo Kim, Myung-Shin Kim
Analytical and Potential Clinical Performance of Oncomine Myeloid Research Assay for Myeloid Neoplasms. Molecular diagnosis & therapy 24 (5) (2021)
Jae-Ho Yoon, Gi June Min, Sung Soo Park, Silvia Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Chang-Ki Min, Seok-Goo Cho, Dong-Wook Kim, Jong Wook Lee, Hee-Je Kim, Sung-Eun Lee
Incidence and risk factors of hepatic veno-occlusive disease/sinusoidal obstruction syndrome after allogeneic hematopoietic cell transplantation in adults with prophylactic ursodiol and intravenous heparin or prostaglandin E1. Bone marrow transplantation 56 (7) (2021)
Raeseok Lee, Sung-Yeon Cho, Dong-Gun Lee, Hyeah Choi, Silvia Park, Byung-Sik Cho, Yoo-Jin Kim, Hee-Je Kim
Infections of Venetoclax-Based Chemotherapy in Acute Myeloid Leukemia: Rationale for Proper Antimicrobial Prophylaxis. Cancers 13 (24) (2021)
Hee-Je Kim, Yonggoo Kim, Dain Kang, Hoon Seok Kim, Jong-Mi Lee, Myung-Shin Kim, Byung-Sik Cho
Prognostic value of measurable residual disease monitoring by next-generation sequencing before and after allogeneic hematopoietic cell transplantation in acute myeloid leukemia. Blood cancer journal 11 (6) (2021)
Byung-Sik Cho, Gi-June Min, Sung-Soo Park, Silvia Park, Young-Woo Jeon, Seung-Hwan Shin, Seung-Ah Yahng, Jae-Ho Yoon, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Sung-Eun Lee, Chang-Ki Min, Seok-Goo Cho, Dong-Wook Kim, Jong Wook Lee, Myung-Shin Kim, Yonggoo Kim, Hee-Je Kim
Prognostic values of D816V KIT mutation and peri-transplant CBFB-MYH11 MRD monitoring on acute myeloid leukemia with CBFB-MYH11. Bone marrow transplantation 56 (11) (2021)
Byung-Sik Cho, Gi-June Min, Sung Soo Park, Silvia Park, Young-Woo Jeon, Seung-Hwan Shin, Seung-Ah Yahng, Jae-Ho Yoon, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Dong-Wook Kim, Jong Wook-Lee, Myung-Shin Kim, Yong-Goo Kim, Hee-Je Kim
Prognostic Impacts of D816V KIT Mutation and Peri-Transplant RUNX1-RUNX1T1 MRD Monitoring on Acute Myeloid Leukemia with RUNX1-RUNX1T1. Cancers 13 (2) (2021)
Chaiho Jeong, Hee-Je Kim, Seok Lee, Moo Il Kang, Jeonghoon Ha
Effect of Denosumab on Bone Mineral Density of Hematopoietic Stem Cell Transplantation Recipients. International journal of endocrinology 2020 (2020)
Bo-Reum Kim, Seung-Hyun Jung, A-Reum Han, Gyeongsin Park, Hee-Je Kim, Bin Yuan, Venkata Lokesh Battula, Michael Andreeff, Marina Konopleva, Yeun-Jung Chung, Byung-Sik Cho
CXCR4 Inhibition Enhances Efficacy of FLT3 Inhibitors in FLT3-Mutated AML Augmented by Suppressed TGF-b Signaling. Cancers 12 (7) (2020)
Jae-Ho Yoon, Gi June Min, Sung Soo Park, Silvia Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, Chang-Ki Min, Seok-Goo Cho, Jong-Wook Lee, Sung-Eun Lee
Impact of donor type on long-term graft-versus-host disease-free/relapse-free survival for adult acute lymphoblastic leukemia in first remission. Bone marrow transplantation 56 (4) (2020)
Ki Hyun Park, Ji Hyeong Ryu, Hyunjoo Bae, Sojeong Yun, Joo Hee Jang, Kyungja Han, Byung Sik Cho, Hee-Je Kim, Hyeyoung Lee, Eun Jee Oh
Delayed NK Cell Reconstitution and Reduced NK Activity Increased the Risks of CMV Disease in Allogeneic-Hematopoietic Stem Cell Transplantation. International journal of molecular sciences 21 (10) (2020)
Jiyoun Jung, Hye-Ran Choi, Byung-Sik Cho, Silvia Park, Jun-Pyo Myong, Mo-Yeol Kang, Hee-Je Kim
Establishment and operation of a cooperative program to identify work-related acute myeloid leukemia in a general hospital. Annals of occupational and environmental medicine 31 (2019)
Sung-Eun Lee, Ji-Young Lim, Da-Bin Ryu, Tae Woo Kim, Young-Woo Jeon, Jae-Ho Yoon, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, Seok Lee, Seok-Goo Cho, Dong-Wook Kim, Jong Wook Lee, Woo-Sung Min, Chang-Ki Min
Circulating CD3+CD4+CD161+ Cells Are Associated with Early Complications after Autologous Stem Cell Transplantation in Multiple Myeloma. BioMed research international 2018 (2018)
Sung-Eun Lee, Jae-Ho Yoon, Seung-Hwan Shin, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, Seok Lee, Seok-Goo Cho, Jong Wook Lee, Woo-Sung Min, Chong-Won Park, Myung-Shin Kim, Chang-Ki Min
Bone marrow plasma cell assessment before peripheral blood stem cell mobilization in patients with multiple myeloma undergoing autologous stem cell transplantation. BioMed research international 2014 (2014)

Hee-Je Kim.css-eqlu8i{font-size:small;padding-left:4px;} (Kim Hee-Je, Hee Je Kim)

Publication Activity (10 Years)

Top Topics

Top Venues

Hee-Je Kim (Kim Hee-Je, Hee Je Kim)